Literature DB >> 13463081

Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.

I H SCHEINBERG, A G MORELL.   

Abstract

Entities:  

Keywords:  COPPER/in blood; HEPATOLENTICULAR DEGENERATION/blood in

Mesh：

Substances：

Year:  1957        PMID： 13463081      PMCID： PMC1072710          DOI： 10.1172/JCI103515

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  Copper metabolism in man.

Authors:  C J GUBLER
Journal:  J Am Med Assoc       Date:  1956-06-09

2.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

3.  Metabolism of copper in hepatolenticular degeneration.

Authors:  W T ZIMDAHL; I HYMAN; E D COOK
Journal:  Neurology       Date:  1953-08       Impact factor: 9.910

4.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

5.  Oxidase reactions in human plasma caused by coeruloplasmin.

Authors:  C G HOLMBERG; C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

6.  The copper of ascorbic acid oxidase; exchange studies with radioactive copper.

Authors:  M JOSELOW; C R DAWSON
Journal:  J Biol Chem       Date:  1951-07       Impact factor: 5.157

7.  The copper of ascorbic acid oxidase; experiments with an ion exchange resin.

Authors:  M JOSELOW; C R DAWSON
Journal:  J Biol Chem       Date:  1951-07       Impact factor: 5.157

8.  Experimental Copper Poisoning.

Authors:  F B Mallory; F Parker
Journal:  Am J Pathol       Date:  1931-07       Impact factor: 4.307

9.  The Relation of Chronic Poisoning with Copper to Hemochromatosis.

Authors:  F B Mallory
Journal:  Am J Pathol       Date:  1925-01       Impact factor: 4.307

10.  Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

Authors:  H MARKOWITZ; C J GUBLER; J P MAHONEY; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808
View more
  20 in total

1.  ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.

Authors:  I STERNLIEB; H D JANOWITZ
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  OBSERVATIONS ON THE NATURE OF THE UNDERLYING DISORDER AND THE OCCURRENCE OF ASSOCIATED PLASMA TRANSPORT ABNORMALITIES IN A PATIENT WITH AN IDIOPATHIC INCREASE IN THE PLASMA THYROXINE-BINDING GLOBULIN.

Authors:  S H INGBAR; C WATERHOUSE; P CUSHMAN
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

3.  OBSERVATIONS ON THE MECHANISM OF ABSORPTION OF COPPER BY THE SMALL INTESTINE.

Authors:  R F CRAMPTON; D M MATTHEWS; R POISNER
Journal:  J Physiol       Date:  1965-05       Impact factor: 5.182

4.  The effects of some ions and chelating agents on the oxidase activity of caeruloplasmin.

Authors:  G CURZON
Journal:  Biochem J       Date:  1960-10       Impact factor: 3.857

5.  The treatment of hepatolenticular degeneration.

Authors:  J N CUMINGS
Journal:  Proc R Soc Med       Date:  1959-01

6.  Observations on ceruloplasmin in Wilson's disease.

Authors:  A SASS-KORTSAK; M CHERNIAK; D W GEIGER; R J SLATER
Journal:  J Clin Invest       Date:  1959-10       Impact factor: 14.808

7.  A family study of the biochemical defects in Wilson's disease.

Authors:  J F Soothill; J D Blainey; F C Neale; M Fischer-Williams; S C Melnick
Journal:  J Clin Pathol       Date:  1961-05       Impact factor: 3.411

8.  DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.

Authors:  I Sternlier; A G Morell; C D Bauer; B Combes; S De Bobes-Sternberg; I H Schein-Berg
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

9.  THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors:  I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

10.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.